
51 - 200 employés
Fondée en 2004
🧬 Biotechnologie
💊 Pharmaceutique
💰 €75 000 000 Post IPO equity en 2024-02
Biotechnology • Pharmaceuticals
Liquidia est une entreprise biopharmaceutique se concentrant sur le développement de thérapies inhalées pour les maladies cardiopulmonaires rares, en particulier l'hypertension artérielle pulmonaire (HTAP) et l'hypertension pulmonaire associée à une maladie pulmonaire interstitielle (HP-MPI). La société s'appuie sur sa technologie propriétaire d'ingénierie de particules PRINT® pour créer des formulations et des méthodes de livraison exclusives visant à améliorer l'efficacité, la tolérance et la commodité des médicaments inhalés ; son portefeuille comprend le trépostinil inhalé (produit commercial) et des candidats en phase clinique comme le L606. Liquidia met l'accent sur le soutien aux patients, le développement clinique et la progression des thérapies pour de meilleurs résultats respiratoires.
🕒 il y a 7 jours
🗣️🇺🇸🇬🇧 Anglais requis
Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

51 - 200 employés
Fondée en 2004
🧬 Biotechnologie
💊 Pharmaceutique
💰 €75 000 000 Post IPO equity en 2024-02
Biotechnology • Pharmaceuticals
Liquidia est une entreprise biopharmaceutique se concentrant sur le développement de thérapies inhalées pour les maladies cardiopulmonaires rares, en particulier l'hypertension artérielle pulmonaire (HTAP) et l'hypertension pulmonaire associée à une maladie pulmonaire interstitielle (HP-MPI). La société s'appuie sur sa technologie propriétaire d'ingénierie de particules PRINT® pour créer des formulations et des méthodes de livraison exclusives visant à améliorer l'efficacité, la tolérance et la commodité des médicaments inhalés ; son portefeuille comprend le trépostinil inhalé (produit commercial) et des candidats en phase clinique comme le L606. Liquidia met l'accent sur le soutien aux patients, le développement clinique et la progression des thérapies pour de meilleurs résultats respiratoires.
• Draft manuscripts, review articles, congress abstracts, posters, and oral presentations across the PAH/PH-ILD portfolio. • Support the development of the publication plan and timeline in coordination with the publications lead, ensuring alignment with data readouts, congress calendars, and cross-functional review cycles. • Manage publication vendors, coordinate author and steering committee reviews, and maintain the publication tracking database. • Ensure compliance with Good Publication Practice (GPP 2022) and ICMJE authorship standards throughout. • Support the development of the core scientific platform, disease-state education materials, clinical data decks, and product scientific narrative documents. • Build and maintain the MSL slide library, MSL training materials, FAQs, and scientific response letters. • Support the medical review process for promotional and non-promotional materials as needed. • Translate complex clinical and scientific data into clear, scientifically balanced content for HCP, payer, and internal audiences. • Support the development and maintenance of Standard Response Letters and literature/scientific digests. • Support responses to unsolicited scientific inquiries and keep the Medical Information reference library current. • Support engagement with KOLs, advocacy organizations, and professional societies through scientifically accurate written content. • Partner with Advocacy and Field Medical to ensure materials reflect current data and support relationship-building objectives. • Develop advisory board materials, investigator meeting presentations, and post-meeting scientific summaries. • Support scientific content development for congress activities: abstracts, posters, symposia materials, and booth/exhibit scientific content. • Support pre- and post-congress activity, including competitive intelligence summaries and internal debrief materials. • Align content development with Liquidia's tiered Congress Strategy framework and KOL engagement standards. • Partner with Medical Directors, Field Medical, Clinical Innovation & Strategic Engagement, HEOR/Market Access, Regulatory, and Legal/Compliance to ensure scientific accuracy, balance, and regulatory compliance across all deliverables. • Coordinate with Commercial on non-promotional review as needed.
• Advanced scientific degree preferred (PharmD, PhD, MD, or MS in Life Sciences); strong candidates with a BS and significant relevant writing experience will also be considered. • Meaningful pharmaceutical medical writing experience, ideally including direct Medical Affairs experience. • Demonstrated end-to-end publication management experience (GPP 2022/ICMJE fluency required). • Strong track record developing congress abstracts, posters, and scientific presentations. • Excellent scientific writing, editing, and communication skills. • Pulmonary hypertension, rare disease, respiratory, or orphan drug experience. • Familiarity with AMA style, medical review committee (MRC) processes, and publication/medical communication tools (e.g., EndNote, Veeva Vault). • Exceptional scientific writing and editing with strong attention to accuracy and balance. • Ability to translate complex clinical/scientific data for varied audiences. • Strong project management skills; able to manage multiple concurrent projects against tight congress/publication deadlines. • Effective cross-functional and stakeholder management, including with external authors and vendors. • Working understanding of evidence generation and dissemination strategy.
• Medical • Dental • Vision • STD • LTD • 401(k) Savings Retirement Plan • ESPP • and more!
Postuler Maintenant🕒 il y a 8 jours
Senior Medical Writer collaborating with cross-functional teams to develop regulatory clinical evidence documents. Ensuring compliance with FDA and EU regulations while mentoring junior writers.
🇺🇸 États-Unis – Télétravail
💰 €4 248 192 Venture Round - Cianna Medical en 2016-10
⏰ Temps Plein
🟠 Senior
🏥📝 Rédacteur Médical
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 9 jours
CDI Specialist managing comprehensive clinical chart reviews to enhance documentation quality and compliance. Collaborates with various healthcare professionals to assure regulatory standards are met.
🇺🇸 États-Unis – Télétravail
💵 $74 000 - $124 000 / an
💰 Grant en 2023-02
⏰ Temps Plein
🟡 Intermédiaire
🟠 Senior
🏥📝 Rédacteur Médical
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 9 jours
Supervisor leading clinical documentation integrity program in healthcare system, overseeing operations and enhancing standards. Collaborating with various teams to improve patient outcomes.
🇺🇸 États-Unis – Télétravail
🔥 Financement dans la dernière année
💰 €20 000 Grant - Trinity Health en 2025-10
⏰ Temps Plein
🟡 Intermédiaire
🟠 Senior
🏥📝 Rédacteur Médical
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 9 jours
Senior Medical Writer authoring clinical documents for Parexel, managing writing projects and ensuring quality control on documents.
🇺🇸 États-Unis – Télétravail
💰 Venture Round en 1990-01
⏰ Temps Plein
🟠 Senior
🏥📝 Rédacteur Médical
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 9 jours
Sr Medical Writer managing medical writing deliverables in late-phase studies for Syneos Health. Collaborating across teams to ensure compliance and quality in scientific documentation.
🇺🇸 États-Unis – Télétravail
💵 $70 100 - $145 000 / an
⏰ Temps Plein
🟠 Senior
🏥📝 Rédacteur Médical
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis